Migraine Prophylaxis with Divalproex
Abstract
The effectiveness and safety of divalproex sodium administered daily in migraine prophylaxis were evaluated in 23 children, ages 7 to 17 years (mean, 12.4 yrs), at Ohio State University College of Medicine, Children’s Hospital, Columbus, OH.
DOI: https://doi.org/10.15844/pedneurbriefs-15-12-3 | Journal eISSN: 2166-6482
Language: English
Page range: 91 - 91
Published on: Dec 1, 2001
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.